1-3 of 3
Raymond H. Liang
Close
Sort by
Journal Articles

Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)–cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation

Lijun Shen, Wing-Yan Au, Tianhuan Guo, Kai-Yau Wong, Michelle L. Wong, Junjiro Tsuchiyama, Po-Wing Yuen, Yok-Lam Kwong, Raymond H. Liang, Gopesh Srivastava
Journal: Blood
Blood (2007) 110 (1): 469–470.
https://doi.org/10.1182/blood-2007-02-072900
Published: 2007
Journal Articles

High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6 -deregulating mutations, in gastric lymphoma

Clinical Trials & Observations
Yun-Wen Chen, Xiao-Tong Hu, Anthony C. Liang, Wing-Yan Au, Chi-Chiu So, Michelle L. Wong, Lijun Shen, Qian Tao, Kent-Man Chu, Yok-Lam Kwong, Raymond H. Liang, Gopesh Srivastava
Journal: Blood
Blood (2006) 108 (7): 2373–2383.
https://doi.org/10.1182/blood-2006-05-022517
Published: 2006
Includes: Supplemental data
Journal Articles

Treatment of Relapsed Acute Promyelocytic Leukemia by Arsenic-Based Strategies without Hematopoietic Stem Cell Transplantation in Hong Kong: A Seven-Year Experience.

Wing Y. Au, MD, James C. Chim, MD, Albert K. Lie, MD, Cyrus R. Kumana, MD, Anskar Y. Leung, MD, Eric W. Tse, MD, Shing Y. Ma, MD, Raymond H. Liang, MD, Yok L. Kwong, MD
Journal: Blood
Blood (2004) 104 (11): 395.
https://doi.org/10.1182/blood.V104.11.395.395
Published: 2004